相关实验视频
Updated: May 2, 2026

05:53
Intraoperative Ultrasound in Spinal Surgery
Published on: August 17, 2022
4.6K
由于大量的出血成分,具有自发回归的圣骨带瘤
Tania Marlem Chico González1,2, Suk Wai Lam1,3, Robert van der Wal1,4
1LUMC: Leiden University Medical Center, Leiden, Netherlands.
Skeletal radiology
|May 12, 2024
概括
骨瘤,罕见的骨瘤,可以由于内出血而表现出自发的大小缩小. 这凸显了活检在疑似冠状腺瘤病例中为准确诊断的重要性.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 病理学 病理学 病理学
背景情况:
- 冠状瘤是一种罕见的恶性骨瘤,由冠状腺残留物产生的.
- 它最常见的是影响神经骨区域和脊柱.
- 放射性特征有时可以模仿其他条件,需要仔细解释.
研究的目的:
- 为了呈现一个带有异常成像发现的胸膜瘤病例.
- 为了强调由于出血而导致的自发瘤大小变化的潜力.
- 突出诊断挑战和活检的重要性.
主要方法:
- 一个70岁的男性的病例介绍,怀疑患有瘤.
- 审查MRI发现,包括T1和T2加权图像.
- 4周间隔前后成像的比较.
- 活检用于确定的诊断.
主要成果:
- 最初的核磁共振扫描显示了带有神经前部软组织组成部分的瘤.
- 随后的MRI显示了显著的自发瘤缩.
- 差异性诊断包括感染或在逆肠道囊出血.
- 活检证实了心脏瘤,揭示了大量的出血成分.
结论:
- 冠状瘤可能会出现内出血,导致明显的自发缩小.
- 放射科医生必须在对瘤大小波动的差异诊断中考虑出血事件.
- 准确的诊断依赖于将成像检测结果与通过活检的组织病理学确认相结合.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Hematopoiesis
8.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K

